An observational study in Upper Extremity Injury, sponsored by Sahmyook University. Not yet recruiting. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2025-12-12.
Sponsored by Sahmyook University · Observational
This study aims to investigate the differences in recovery periods of upper extremity injuries among indoor climbers according to their treatment methods.
The research focuses on comparing the recovery duration, specifically the time to return to climbing, between those who received professional physical therapy and those who relied on self-treatment or other conservative management.
Additionally, this survey-based observational study seeks to explore how individual and training-related factors - such as warm-up duration, climbing frequency, and years of experience - affect the occurrence and recurrence of upper extremity injuries.
Participants will complete an online questionnaire consisting of demographic data, climbing habits, injury characteristics, treatment methods, and recovery outcomes.
The data will be collected anonymously and analyzed to determine whether the type of treatment correlates with faster recovery or reduced reinjury risk.
The findings are expected to provide foundational evidence for developing effective rehabilitation and injury-prevention strategies for indoor climbers, and to guide clinicians and trainers in selecting appropriate treatment approaches for upper extremity injuries.
This cross-sectional survey will recruit indoor climbers aged 18-50 who have experienced upper extremity injuries within the past 12 months.
The questionnaire includes sections on injury site and type (e.g., finger, wrist, elbow, shoulder; tendonitis, ligament injury, or muscle tear), treatment method (self-care, physical therapy, injection, surgery, or rehabilitation exercise), treatment duration, and perceived recovery status.
Statistical analysis will be performed to compare mean recovery periods among treatment groups and to examine correlations with demographic and behavioral factors.
The study was approved by the Institutional Review Board of Sahmyook University (IRB No. 2025-06-034-002).
Results from this research may contribute to improved understanding of injury management and evidence-based rehabilitation for indoor climbers.
63 studies on the registry are indexed under Arm Injuries; 10 are open to participants now.
This study's planned enrollment of 300 is above the median of 101 across 16 observational studies indexed under Arm Injuries.
Browse Arm Injuries studies →Sahmyook University is the lead sponsor of 42 studies on the registry; 10 are open to participants now.
Counted across the registry records on this site, refreshed daily.
This study will include indoor climbers aged 18 to 50 who experienced an upper extremity injury related to climbing within the past 12 months and received any form of treatment. Participants will be recruited from climbing communities, gyms, and online platforms. Only non-professional climbers will be included to ensure generalizability to the general indoor climbing population.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants who treated their upper extremity injury through self-managed care such as rest, cold/heat therapy, taping, or over-the-counter medication.
Participants who received professional non-surgical physical therapy, including manual therapy, therapeutic exercise, or extracorporeal shockwave therapy.
Participants who received non-surgical injection treatments such as prolotherapy, PRP, or steroid injections for upper extremity injury.
Participants who underwent surgical or invasive procedures followed by rehabilitation or exercise-based recovery programs.
Mean Recovery Duration (Weeks) According to Treatment Type
The average number of weeks required for indoor climbers to achieve full recovery and return to climbing after upper extremity injury, compared across treatment types (self-care, physical therapy, injection, surgery/rehabilitation).
Time frame: 12 months (retrospective survey)
Reinjury Rate Within 12 Months
Proportion of indoor climbers who experienced a recurrent upper-extremity injury in the same anatomical region within the past 12 months.
Time frame: 12 months
Pain Resolution Duration (Weeks)
Number of weeks required for complete pain resolution after upper-extremity injury, based on participant recall.
Time frame: 12 months (retrospective survey)
Return-to-Climbing Criteria (Self-Reported)
Self-reported criteria participants used to determine readiness to resume climbing after upper-extremity injury (e.g., full pain resolution, daily activity tolerance, strength recovery).
Time frame: 12 months
No study locations are listed for this record.
Plan to share: No — This study does not collect individual participant data (IPD) such as raw clinical data or identifiable records. All survey responses are anonymized, aggregated, and analyzed at the group level. Therefore, there is no IPD available to share.
This study is not yet recruiting, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sahmyook University